robert j. motzer, m.d., receives schonfeld award from kidney cancer association
Published 13 years ago • 210 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
6:58
panel discussion #1
-
2:32
dr. robert motzer discusses the safety and efficacy of tivozanib in kidney cancer
-
10:57
kidney cancer association
-
3:55
drugs for metastatic kidney cancer offer similar survival
-
24:47
kidney cancer association
-
1:11
dr. motzer on the milestone of immunotherapy in rcc
-
1:25
dr. motzer discusses nivolumab for mrcc
-
3:27
kidney cancer stages
-
1:52:20
the "brilliant" kidney
-
22:26
dr. mark girgis: pancreatic cancer progress report: where are we?
-
10:57
the tumor microenvironment in rcc? isaac witz, m.d.
-
6:19
asco gu 2013: tivo 1 study shows tivozanib an option for renal cell carcinoma: dr robert motzer
-
1:10
kidney cancer association awarded four stars
-
1:56
dr. robert motzer reviews the phase iii comparz study
-
2:32
dr. motzer on sunitinib versus pazopanib in renal cell carcinoma
-
2:33
dr. robert motzer reviews the tivo-1 study survival findings
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
3:02
robert j. glaser award mark linzer, md
-
1:57
dr. motzer on nivolumab versus everolimus in renal call carcinoma
-
1:55
welcome and introduction by kidney cancer association ceo bill bro
-
10:40
dr robert motzer, genitourinary oncol service, memorial sloan-kettering cancer center, new york/usa